Imnunocore任命Travis Coy为首席财务官,利用他在生物技术领域20多年的经验。 Immunocore appoints Travis Coy as CFO, leveraging his 20+ years of experience in biotech.

Imnunocore是一家开发新免疫疗法的生物技术公司,已任命Travis Coy为新的首席财务官兼公司发展负责人。 Immunocore, a biotech company developing new immunotherapies, has appointed Travis Coy as its new Chief Financial Officer and Head of Corporate Development. Coy曾担任公司非执行主任,他从Eli Lilly那里获得了20多年的经验,他在那里领导了业务发展。 Coy, who previously served as a Non-Executive Director at the company, brings over 20 years of experience from Eli Lilly, where he led business development. 任命他的目的是加强该公司的财政和战略增长。 His appointment aims to enhance the company's financial and strategic growth.